ZA9110145B - 14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes - Google Patents
14beta-h-,14-and 15-en-11beta-aryl-4-oestrenesInfo
- Publication number
- ZA9110145B ZA9110145B ZA9110145A ZA9110145A ZA9110145B ZA 9110145 B ZA9110145 B ZA 9110145B ZA 9110145 A ZA9110145 A ZA 9110145A ZA 9110145 A ZA9110145 A ZA 9110145A ZA 9110145 B ZA9110145 B ZA 9110145B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrogen atom
- pct
- bond
- configuration
- together represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0092—Alkenyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
- Luminescent Compositions (AREA)
- Electron Beam Exposure (AREA)
- Amplifiers (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4042004A DE4042004A1 (de) | 1990-12-22 | 1990-12-22 | 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9110145B true ZA9110145B (en) | 1992-11-25 |
Family
ID=6421576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9110145A ZA9110145B (en) | 1990-12-22 | 1991-12-23 | 14beta-h-,14-and 15-en-11beta-aryl-4-oestrenes |
Country Status (14)
Country | Link |
---|---|
US (1) | US5426102A (fi) |
EP (1) | EP0567469B1 (fi) |
JP (1) | JP3048636B2 (fi) |
CN (1) | CN1066271A (fi) |
AT (1) | ATE157372T1 (fi) |
AU (1) | AU659118B2 (fi) |
CA (1) | CA2099016A1 (fi) |
DE (2) | DE4042004A1 (fi) |
FI (1) | FI932872A0 (fi) |
HU (1) | HUT65320A (fi) |
IE (1) | IE914530A1 (fi) |
PT (1) | PT99910B (fi) |
WO (1) | WO1992011278A1 (fi) |
ZA (1) | ZA9110145B (fi) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
EP0900234B1 (en) * | 1996-05-01 | 2000-07-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 21-substituted progesterone derivatives as new antiprogestational agents |
US6090798A (en) * | 1997-12-19 | 2000-07-18 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with glucocorticoid antagonists |
CA2516319C (en) * | 2003-02-28 | 2012-09-18 | The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services | Method for preparing 17.alpha.-acetoxy-11.beta.-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
DE102007011105A1 (de) * | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
PL2576582T3 (pl) | 2010-05-26 | 2020-06-29 | Corcept Therapeutics, Inc. | Leczenie dystrofii mięśniowej |
EP3265127B1 (en) | 2015-03-02 | 2024-02-21 | Corcept Therapeutics, Inc. | Mifepristone and octreotide for use in the treatment of cushing's syndrome in a patient having an adrenocorticotropic hormone (acth)-secreting pancreatic neuroendocrine tumor |
MX2017011885A (es) | 2015-03-30 | 2018-02-19 | Corcept Therapeutics Inc | Uso de antagonistas de receptores de glucocorticoides en combinacion con glucocorticoides para tratar la insuficiencia adrenal. |
ES2865334T3 (es) | 2015-08-13 | 2021-10-15 | Corcept Therapeutics Inc | Método de diagnóstico diferencial de síndrome de Cushing dependiente de ACTH |
KR102197526B1 (ko) | 2016-01-19 | 2020-12-31 | 코어셉트 쎄라퓨틱스 인코포레이티드 | 이소성 쿠싱 증후군의 감별 진단 |
CA3065555A1 (en) | 2017-06-20 | 2018-12-27 | Corcept Therapeutics, Inc. | Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators |
US20240269280A1 (en) | 2020-12-18 | 2024-08-15 | Instil Bio (Uk) Limited | Processing of tumor infiltrating lymphocytes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
US4780461A (en) * | 1983-06-15 | 1988-10-25 | Schering Aktiengesellschaft | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same |
DE3506785A1 (de) * | 1985-02-22 | 1986-08-28 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
DE3625315A1 (de) * | 1986-07-25 | 1988-01-28 | Schering Ag | 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate |
US5272140A (en) * | 1987-01-23 | 1993-12-21 | Akzo N.V. | 11-aryl steroid derivatives |
DE3723788A1 (de) * | 1987-07-16 | 1989-01-26 | Schering Ag | 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate |
JP2785023B2 (ja) * | 1987-12-30 | 1998-08-13 | ルセル―ユクラフ | 17α位置を置換された17β―OH―19―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物 |
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
DE3832303A1 (de) * | 1988-09-20 | 1990-04-12 | Schering Ag | 11ss-phenyl-14ssh-steroide |
-
1990
- 1990-12-22 DE DE4042004A patent/DE4042004A1/de not_active Withdrawn
-
1991
- 1991-12-20 PT PT99910A patent/PT99910B/pt not_active IP Right Cessation
- 1991-12-21 AU AU91110/91A patent/AU659118B2/en not_active Ceased
- 1991-12-21 WO PCT/EP1991/002494 patent/WO1992011278A1/de active IP Right Grant
- 1991-12-21 JP JP4501406A patent/JP3048636B2/ja not_active Expired - Lifetime
- 1991-12-21 DE DE59108837T patent/DE59108837D1/de not_active Expired - Fee Related
- 1991-12-21 CA CA002099016A patent/CA2099016A1/en not_active Abandoned
- 1991-12-21 EP EP92901304A patent/EP0567469B1/de not_active Expired - Lifetime
- 1991-12-21 AT AT92901304T patent/ATE157372T1/de not_active IP Right Cessation
- 1991-12-21 HU HU9301813A patent/HUT65320A/hu unknown
- 1991-12-21 US US08/081,269 patent/US5426102A/en not_active Expired - Fee Related
- 1991-12-21 CN CN91112815A patent/CN1066271A/zh active Pending
- 1991-12-23 IE IE453091A patent/IE914530A1/en not_active IP Right Cessation
- 1991-12-23 ZA ZA9110145A patent/ZA9110145B/xx unknown
-
1993
- 1993-06-21 FI FI932872A patent/FI932872A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE4042004A1 (de) | 1992-06-25 |
IE914530A1 (en) | 1993-06-30 |
EP0567469A1 (de) | 1993-11-03 |
EP0567469B1 (de) | 1997-08-27 |
PT99910B (pt) | 1999-06-30 |
FI932872A (fi) | 1993-06-21 |
HUT65320A (en) | 1994-05-02 |
CN1066271A (zh) | 1992-11-18 |
DE59108837D1 (de) | 1997-10-02 |
WO1992011278A1 (de) | 1992-07-09 |
US5426102A (en) | 1995-06-20 |
JP3048636B2 (ja) | 2000-06-05 |
JPH06505708A (ja) | 1994-06-30 |
CA2099016A1 (en) | 1992-06-23 |
ATE157372T1 (de) | 1997-09-15 |
FI932872A0 (fi) | 1993-06-21 |
HU9301813D0 (en) | 1993-09-28 |
AU659118B2 (en) | 1995-05-11 |
AU9111091A (en) | 1992-07-22 |
PT99910A (pt) | 1992-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU659118B2 (en) | 14beta-H-, 14- and 15-EN-11beta -aryl-4-estrenes | |
IL105078A (en) | Pharmaceutical compositions containing 17-(3-pyridyl)- substituted steroids and some new compounds of this type | |
KR950700318A (ko) | 알칼리 금속 8,9-데하이드로에스트론 설페이트 에스테르(Alkali metal 8,9-dehydroestrone sulfate esters) | |
AU3357093A (en) | Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids | |
PT79839A (en) | Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith | |
AU664543B2 (en) | D-homo-(16-EN)-11beta -aryl-4-estrenes, process for producing them and their use as medicaments | |
ZA9110144B (en) | 6,7-modified 11beta-aryl-4-oestrenes | |
ES8702429A1 (es) | Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos | |
HUP0300887A2 (hu) | Szteroid szerkezeteket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
DE50110892D1 (de) | 17alpha-fluoralkylsteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
IL107232A0 (en) | 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
ES8407023A1 (es) | Un procedimiento para la preparacion de 4-(3-trifluormetilfenil-1,2,3,6-tetrahidropiridinas | |
NO932276L (no) | D-homo-(16-en)-11beta-aryl-4-oestrener, fremgangsmaate for deres fremstilling, saa vel som deres anvendelse som legemiddel | |
MX9707610A (es) | Derivados de fenoxietilamina que tienen una afinidad elevada hacia el receptor 5-ht1a, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que los contienen. | |
GB928493A (en) | Steroid compounds | |
RU95117929A (ru) | Фармацевтическая композиция, ингибирующая костную резорбцию или промотирующая остеогенез | |
HUP0302020A2 (hu) | 2-Szubsztituált pregna-1,3,5,(10)-trién- és kola-1,3,5(10)-trién-származékok, eljárás elżállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
CA2431355A1 (en) | 14.beta., 16,17-methylene steroids as novel androgens |